DIONOSIL AQUEOUS Drug Patent Profile
When do Dionosil Aqueous patents expire, and what generic alternatives are available?
Dionosil Aqueous is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in DIONOSIL AQUEOUS is propyliodone. There is one drug master file entry for this compound. Additional details are available on the propyliodone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIONOSIL AQUEOUS?
- What are the global sales for DIONOSIL AQUEOUS?
- What is Average Wholesale Price for DIONOSIL AQUEOUS?
Summary for DIONOSIL AQUEOUS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 601 |
| DailyMed Link: | DIONOSIL AQUEOUS at DailyMed |
US Patents and Regulatory Information for DIONOSIL AQUEOUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | DIONOSIL AQUEOUS | propyliodone | SUSPENSION;INTRATRACHEAL | 009309-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
